328 related articles for article (PubMed ID: 19339632)
1. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
Huang S; Zhang A; Ding G; Chen R
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632
[TBL] [Abstract][Full Text] [Related]
2. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
Yuan Y; Zhang A; Huang S; Ding G; Chen R
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor.
Ghosh PM; Mikhailova M; Bedolla R; Kreisberg JI
Am J Physiol Renal Physiol; 2001 Jun; 280(6):F972-9. PubMed ID: 11352836
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A.
Terada Y; Kobayashi T; Kuwana H; Tanaka H; Inoshita S; Kuwahara M; Sasaki S
J Am Soc Nephrol; 2005 Aug; 16(8):2296-305. PubMed ID: 15975997
[TBL] [Abstract][Full Text] [Related]
7. EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway.
Chiu T; Santiskulvong C; Rozengurt E
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G182-94. PubMed ID: 15358595
[TBL] [Abstract][Full Text] [Related]
8. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling.
Akool el-S; Gauer S; Osman B; Doller A; Schulz S; Geiger H; Pfeilschifter J; Eberhardt W
Biochem Pharmacol; 2012 Jan; 83(2):286-95. PubMed ID: 22100870
[TBL] [Abstract][Full Text] [Related]
10. Beyond Gap Junction Channel Function: the Expression of Cx43 Contributes to Aldosterone-Induced Mesangial Cell Proliferation via the ERK1/2 and PKC Pathways.
Zhang A; Han Y; Wang B; Li S; Gan W
Cell Physiol Biochem; 2015; 36(3):1210-22. PubMed ID: 26138882
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor.
Iwasaki H; Eguchi S; Ueno H; Marumo F; Hirata Y
Endocrinology; 1999 Oct; 140(10):4659-68. PubMed ID: 10499523
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
[TBL] [Abstract][Full Text] [Related]
13. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
Lee MY; Jo SD; Lee JH; Han HJ
J Cell Biochem; 2008 Dec; 105(6):1410-9. PubMed ID: 18980246
[TBL] [Abstract][Full Text] [Related]
14. Ammonia-induced Na,K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling.
Dai H; Song D; Xu J; Li B; Hertz L; Peng L
Neurochem Int; 2013 Nov; 63(6):610-25. PubMed ID: 24044899
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
16. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
17. CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation.
Ravasi S; Citro S; Viviani B; Capra V; Rovati GE
Respir Res; 2006 Mar; 7(1):42. PubMed ID: 16553950
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion.
Zhou J; Du T; Li B; Rong Y; Verkhratsky A; Peng L
ASN Neuro; 2015; 7(5):. PubMed ID: 26442853
[TBL] [Abstract][Full Text] [Related]
19. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
Liu Y; Fanburg BL
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
[TBL] [Abstract][Full Text] [Related]
20. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
